Taher, E., Swelam, M., Mansy, A., Elgammal, M. (2014). Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study. Journal of High Institute of Public Health, 44(1), 21-24. doi: 10.21608/jhiph.2014.20338
Engy Taher; Manal Swelam; Amr Mansy; Marwa Elgammal. "Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study". Journal of High Institute of Public Health, 44, 1, 2014, 21-24. doi: 10.21608/jhiph.2014.20338
Taher, E., Swelam, M., Mansy, A., Elgammal, M. (2014). 'Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study', Journal of High Institute of Public Health, 44(1), pp. 21-24. doi: 10.21608/jhiph.2014.20338
Taher, E., Swelam, M., Mansy, A., Elgammal, M. Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study. Journal of High Institute of Public Health, 2014; 44(1): 21-24. doi: 10.21608/jhiph.2014.20338
Methotrexate and Misoprostol against Misoprostol Alone for Early Medical Abortion: Comparative Study
Obstetric and Gynecology Department. Faculty of medicine, Alexandria University. Egypt
Abstract
Background: Vaginal mifepristone oral misoprostol have proven to be highly effective medical abortion methods and are used widely in in modern countries. Objectives: The objective of this study is to compare the efficacy for two medical abortion regimens used in one clinic setting misoprostol alone, intramuscular methotrexate and vaginal misoprostol. Methods: An intervention study was conducted on a total of 100 randomly selected women with gestations of first-trimester pregnancy, who sought a missed abortion. Study population was assigned as two groups, the first was subjected to vaginal administration of Misoprostol and the second was subjected to IM injection of methotrexate and self-administration of vaginal misoprostol After 72h. All patients were followed up for recording any side effects of the drugs, progress of abortion & if there was any need for surgical interference [manual vacuum aspiration (MVA) or dilatation and curettage Results: Success rate of the methotrexate regimen was 80% and did not differ significantly from the misoprostol regimen that had success rate of 84%. Conclusions: In this real-use setting, the use of misoprostol in combination with methotrexate or alone for the missed abortion termination are both safe and effective methods without serious side effects.
View on SCiNiTO
Top